TickerLeague

Buyback Spend for Illumina (ILMN)

Buyback Spend for Illumina (ILMN): headline value $742.00M · YoY +539.7%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$742.00M

YoY change

+539.7%

5Y CAGR

+0.2%

Peak year (2025)

$742.00M

Latest annual

$742.00M

Buyback Spend history chart for Illumina (ILMN) from 1999 to 2025

Buyback Spend history table for Illumina (ILMN) from 1999 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$742.00M+539.7%
2024$116.00M
2023$0
2022$0
2021$0-100.0%
2020$736.00M+127.2%
2019$324.00M+61.2%
2018$201.00M-19.9%
2017$251.00M+0.8%
2016$249.00M-9.2%
2015$274.32M+15.7%
2014$237.18M+374.2%
2013$50.02M-39.4%
2012$82.52M-85.5%
2011$570.41M+1195.9%
2010$44.02M-74.9%
2009$175.14M+147.4%
2008$70.78M-71.9%
2007$251.62M
2006$0
2005$0-100.0%
2004$13,000
2003$0
2002$0
2001$0
2000$0
1999$0

Buyback Spend values are taken from Illumina's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Illumina (ILMN) reported buyback spend of $742.00M – surged 539.7% year-over-year.

Through 2020–2025 (5 years), Illumina buyback spend delivered a +0.2% annualised rate; sustaining 2 straight years of year-over-year growth.

Across the available history, buyback spend reached its high of $742.00M in 2025 and its low of $0 in 1999.

Within Healthcare, Illumina (ILMN) ranks 7th among 8 peers we track. The peer median for buyback spend is $2.75B.

Illumina Buyback Spend by Year

Illumina Buyback Spend 2025: $742.00M

Illumina buyback spend in 2025 was $742.00M, surged 539.7% from 2024. This figure represents the highest annual value in the available history.

Illumina Buyback Spend 2024: $116.00M

Illumina buyback spend in 2024 was $116.00M.

Illumina Buyback Spend 2023: $0

Illumina buyback spend in 2023 was $0.

Illumina Buyback Spend 2022: $0

Illumina buyback spend in 2022 was $0.

Illumina Buyback Spend 2021: $0

Illumina buyback spend in 2021 was $0.

See more financial history for Illumina (ILMN).

Sector peers — Buyback Spend

Companies in the same sector as Illumina, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Illumina's buyback spend?

Latest reported buyback spend for Illumina (ILMN) is $742.00M (period ending December 28, 2025).

How has Illumina buyback spend changed year-over-year?

Illumina (ILMN) buyback spend changed +539.7% year-over-year on the latest annual filing.

What is the long-term growth rate of Illumina buyback spend?

Illumina (ILMN) buyback spend compound annual growth rate is +0.2% over the most recent 5 years available.

When did Illumina buyback spend hit its highest annual value?

Illumina buyback spend reached its highest annual value of $742.00M in 2025.

What was Illumina buyback spend in 2024?

Illumina (ILMN) buyback spend in 2024 was $116.00M.

What was Illumina buyback spend in 2025?

Illumina (ILMN) buyback spend in 2025 was $742.00M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.